Literature DB >> 11410931

The ubiquitin-proteasome pathway and proteasome inhibitors.

J Myung1, K B Kim, C M Crews.   

Abstract

The ubiquitin-proteasome pathway has emerged as a central player in the regulation of several diverse cellular processes. Here, we describe the important components of this complex biochemical machinery as well as several important cellular substrates targeted by this pathway and examples of human diseases resulting from defects in various components of the ubiquitin-proteasome pathway. In addition, this review covers the chemistry of synthetic and natural proteasome inhibitors, emphasizing their mode of actions toward the 20S proteasome. Given the importance of proteasome-mediated protein degradation in various intracellular processes, inhibitors of this pathway will continue to serve as both molecular probes of major cellular networks as well as potential therapeutic agents for various human diseases. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11410931      PMCID: PMC2556558          DOI: 10.1002/med.1009

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  259 in total

1.  The base of the proteasome regulatory particle exhibits chaperone-like activity.

Authors:  B C Braun; M Glickman; R Kraft; B Dahlmann; P M Kloetzel; D Finley; M Schmidt
Journal:  Nat Cell Biol       Date:  1999-08       Impact factor: 28.824

2.  Chemical denaturation and modification of ovalbumin alters its dependence on ubiquitin conjugation for class I antigen presentation.

Authors:  M T Michalek; E P Grant; K L Rock
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

3.  Does this have a familiar RING?

Authors:  A J Saurin; K L Borden; M N Boddy; P S Freemont
Journal:  Trends Biochem Sci       Date:  1996-06       Impact factor: 13.807

Review 4.  The NF-kappa B and I kappa B proteins: new discoveries and insights.

Authors:  A S Baldwin
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

5.  The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells.

Authors:  V Cerundolo; A Benham; V Braud; S Mukherjee; K Gould; B Macino; J Neefjes; A Townsend
Journal:  Eur J Immunol       Date:  1997-01       Impact factor: 5.532

6.  Activation of the cell death program by inhibition of proteasome function.

Authors:  H C Drexler
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

7.  Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade.

Authors:  L Huang; E Kinnucan; G Wang; S Beaudenon; P M Howley; J M Huibregtse; N P Pavletich
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

8.  Structural and functional characterizations of the proteasome-activating protein PA26 from Trypanosoma brucei.

Authors:  Y Yao; L Huang; A Krutchinsky; M L Wong; K G Standing; A L Burlingame; C C Wang
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

9.  WW domains of Nedd4 bind to the proline-rich PY motifs in the epithelial Na+ channel deleted in Liddle's syndrome.

Authors:  O Staub; S Dho; P Henry; J Correa; T Ishikawa; J McGlade; D Rotin
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

10.  The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB.

Authors:  H L Pahl; B Krauss; K Schulze-Osthoff; T Decker; E B Traenckner; M Vogt; C Myers; T Parks; P Warring; A Mühlbacher; A P Czernilofsky; P A Baeuerle
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more
  124 in total

1.  Complementary whole-genome technologies reveal the cellular response to proteasome inhibition by PS-341.

Authors:  James A Fleming; Eric S Lightcap; Seth Sadis; Vala Thoroddsen; Christine E Bulawa; Ronald K Blackman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

2.  Randomized phase II trial of concurrent versus sequential bortezomib plus docetaxel in advanced non-small-cell lung cancer: a California cancer consortium trial.

Authors:  Primo N Lara; Jeff Longmate; Karen Reckamp; Barbara Gitlitz; Athanassios Argiris; Suresh Ramalingam; Chandra P Belani; Philip C Mack; Derick H M Lau; Mariana Koczywas; John J Wright; Frances A Shepherd; Natasha Leighl; David R Gandara
Journal:  Clin Lung Cancer       Date:  2011-01       Impact factor: 4.785

3.  Cell-cell fusion induced by the avian reovirus membrane fusion protein is regulated by protein degradation.

Authors:  Maya Shmulevitz; Jennifer Corcoran; Jayme Salsman; Roy Duncan
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition.

Authors:  Namrata D Udeshi; D R Mani; Thomas Eisenhaure; Philipp Mertins; Jacob D Jaffe; Karl R Clauser; Nir Hacohen; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2012-04-14       Impact factor: 5.911

5.  Mitophagy selectively degrades individual damaged mitochondria after photoirradiation.

Authors:  Insil Kim; John J Lemasters
Journal:  Antioxid Redox Signal       Date:  2011-03-06       Impact factor: 8.401

Review 6.  Regulation of mitophagy by the ubiquitin pathway in neurodegenerative diseases.

Authors:  Shyamal Desai; Meredith Juncker; Catherine Kim
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-09

7.  Activity dependent localization of synaptic NMDA receptors in spinal neurons.

Authors:  Kenneth M Rosen; Abhay Moghekar; Richard J O'Brien
Journal:  Mol Cell Neurosci       Date:  2006-12-29       Impact factor: 4.314

8.  Proteolysis of the barley receptor-like protein kinase RPG1 by a proteasome pathway is correlated with Rpg1-mediated stem rust resistance.

Authors:  Jayaveeramuthu Nirmala; Stephanie Dahl; Brian J Steffenson; C Gamini Kannangara; Diter von Wettstein; Xianming Chen; Andris Kleinhofs
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

9.  Isolation and structure determination of a proteasome inhibitory metabolite from a culture of Scytonema hofmanni.

Authors:  Sang Hee Shim; George Chlipala; Jimmy Orjala
Journal:  J Microbiol Biotechnol       Date:  2008-10       Impact factor: 2.351

10.  Role of proteases in the pathophysiology of cardiac disease.

Authors:  Raja B Singh; Sucheta P Dandekar; Vijayan Elimban; Suresh K Gupta; Naranjan S Dhalla
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.